Literature DB >> 18425064

The prevalence of cystoid macular oedema on optical coherence tomography in retinitis pigmentosa patients without cystic changes on fundus examination.

M Hajali1, G A Fishman.   

Abstract

PURPOSE: To determine the prevalence of cystoid macular oedema (CME) by optical coherence tomography (OCT) in retinitis pigmentosa (RP) patients with no evidence of cystic macular lesions on fundus examination.
METHODS: We included 63 RP patients with no evidence of cystic-appearing macular changes on fundus examination. All patients underwent a complete ocular examination including best-corrected visual acuity using an ETDRS (Early Treatment Diabetic Retinopathy Study) chart, intraocular pressure measurement, anterior segment examination, and a detailed fundus examination. On 50 of the 63 patients, Fourier-domain OCT was performed using the radial slicer protocol. An additional 13 of the 63 patients were scanned using the macular thickness protocol on a time-domain OCT unit. The diagnosis of CME was defined by the presence of hyporeflective lacunae with well-defined boundaries on at least two of the scans.
RESULTS: The mean age of patients included in the study was 36 years (range 9-71 years). Out of the 63 patients examined, 20 showed CME in at least one eye (32%), whereas 11 patients showed CME in both eyes (18%).
CONCLUSIONS: Our findings demonstrate that a substantial number of RP patients with CME, as determined by OCT, may not show cystic changes by direct ophthalmoscopy or contact lens biomicroscopy. Knowledge of the high frequency for CME in such patients can serve to identify those who may be amenable to current or future treatment strategies of their macular oedema and can potentially impact on future therapeutic trials where visual acuity is used as an outcome measure.

Entities:  

Mesh:

Year:  2008        PMID: 18425064     DOI: 10.1038/eye.2008.110

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  19 in total

1.  Short-term outcomes of subtenon triamcinolone acetonide injections in patients with retinitis pigmentosa-associated cystoid macular edema unresponsive to carbonic anhydrase inhibitors.

Authors:  Buğra Karasu
Journal:  Int Ophthalmol       Date:  2019-11-26       Impact factor: 2.031

2.  Vitreo-macular interface disorders in retinitis pigmentosa.

Authors:  Serena Fragiotta; Tommaso Rossi; Carmela Carnevale; Alessandro Cutini; Stefano Tricarico; Lorenzo Casillo; Gianluca Scuderi; Enzo Maria Vingolo
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-07-19       Impact factor: 3.117

3.  Efficacy of sustained topical dorzolamide therapy for cystic macular lesions in patients with retinitis pigmentosa and usher syndrome.

Authors:  Mohamed A Genead; Gerald A Fishman
Journal:  Arch Ophthalmol       Date:  2010-09

4.  Visual acuity loss in recessive retinitis pigmentosa and its correlation with macular lesions.

Authors:  Azzrah Thobani; Gerald A Fishman; Mohamed Genead; Anastasios Anastasakis
Journal:  Retina       Date:  2011-05       Impact factor: 4.256

5.  Cystic macular oedema on spectral-domain optical coherence tomography in choroideremia patients without cystic changes on fundus examination.

Authors:  M A Genead; G A Fishman
Journal:  Eye (Lond)       Date:  2010-10-22       Impact factor: 3.775

6.  Photoreceptor degeneration changes magnetic resonance imaging features in a mouse model of retinitis pigmentosa.

Authors:  Qing Wang; Sheng-Kwei Song; Huiying Zhang; Bruce A Berkowitz; Shiming Chen; Samuel A Wickline; Junjie Chen
Journal:  Magn Reson Med       Date:  2011-02-17       Impact factor: 4.668

7.  Frequency of cystoid macular edema and vitreomacular interface disorders in genetically solved syndromic and non-syndromic retinitis pigmentosa.

Authors:  João Pedro Marques; Emmanuel Neves; Sara Geada; Ana Luísa Carvalho; Joaquim Murta; Jorge Saraiva; Rufino Silva
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-04-07       Impact factor: 3.535

8.  Diagnostic challenges in retinitis pigmentosa: genotypic multiplicity and phenotypic variability.

Authors:  Susie Chang; Leah Vaccarella; Sunday Olatunji; Colleen Cebulla; John Christoforidis
Journal:  Curr Genomics       Date:  2011-06       Impact factor: 2.236

9.  Compound heterozygosity for a novel and a recurrent MFRP gene mutation in a family with the nanophthalmos-retinitis pigmentosa complex.

Authors:  Juan Carlos Zenteno; Beatriz Buentello-Volante; Miguel A Quiroz-González; Miguel A Quiroz-Reyes
Journal:  Mol Vis       Date:  2009-09-05       Impact factor: 2.367

10.  A rare case of type 3 usher syndrome with bilateral cystoid macular edema treated with topical dorzolamide.

Authors:  Athul Puthalath; Ramanuj Samanta; Neeraj Saraswat; Ajai Agrawal; Anupam Singh; Mahsa Jamil
Journal:  Taiwan J Ophthalmol       Date:  2020-04-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.